You are here

Bydureon

5 Drugmakers Headed Back to the Drawing Board

Motley Fool

Mon, 01/31/11 - 06:54 pm

Arena Pharmaceuticals

Timing Positive For Bydureon

Forbes

Wed, 01/26/11 - 08:38 pm

Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin

Bloomberg

Fri, 10/22/10 - 07:26 am

What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir

Seeking Alpha

Thu, 10/21/10 - 11:07 am

Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug

Bloomberg

Wed, 10/20/10 - 10:46 am

One More Reason That Lilly Must Do A Deal, Fast

Pharmalot

Wed, 10/20/10 - 09:32 am

Alkermes' Drug Approval On Tap

Investors.com

Tue, 10/19/10 - 10:28 pm

FDA's Top Q4 Blockbuster Drug Decisions

Fierce Biotech

Tue, 10/12/10 - 11:26 am

It's All About the Future for Amylin

Motley Fool

Thu, 07/22/10 - 03:49 pm

Amylin's New Diabetes Drug Well Tolerated By Sufferers

CNBC

Mon, 06/28/10 - 02:59 pm

type 2 diabetes

Eli Lilly's New Diabetes Drug

Yahoo/CNBC

Sat, 06/26/10 - 09:26 am

Amylin Soars on Roche’s Diabetes Delay

Barron's

Sat, 06/19/10 - 12:55 pm

type 2 diabetes

Amylin Drug Fails To Beat Generic

Forbes

Tue, 06/15/10 - 12:36 pm

BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010

Medical News Today

Sun, 05/9/10 - 12:49 pm

type 2 diabetes

Pages